Skip to content

WEIKANG BIO-TECHNOLOGY GROUP CO., INC.

CIK 0001484042

← back to feed
Revenue (TTM)
$59.19M
+36.4% YoY Q3 Dec 2012
Net Income (TTM)
$12.25M
+21.3% YoY Q3 Dec 2012
EPS Diluted (TTM)
$0.35
+3.4% YoY Q3 Dec 2012
Gross Margin
54.2%
Q3 Dec 2012
Operating Margin
31.8%
Q3 Dec 2012
Net Margin
20.7%
Q3 Dec 2012
Free Cash Flow (TTM)
$15.57M
Q3 Dec 2012
Cash
$85.52M
Q3 Dec 2012
Total Debt
—
Q3 Dec 2012
Shares Outstanding
35.13M sh
Q3 Dec 2012

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings